Skip to main content
OpenTrials

Clinical trial condition

Ovarian Neoplasms

Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.

296 public trials 52 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Neoplasms trial results

Active, Not Recruiting

Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)

NCT03393884

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • Mitchell Cancer Institute (University of South Alabama) Mobile, Alabama, United States
  • Gynecologic Oncology Associates (Hoag Hospital) Newport Beach, California, United States
  • Innovative Clinical Research Whittier, California, United States
View all 21 locations
View Trial Details
Active, Not Recruiting

Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.

NCT02598219

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +20 more
Locations
  • Polyclinique Urbain V Avignon, France
  • Centre Hospitalier Régional Universitaire Besançon, France
  • Institut Bergonié Bordeaux, France
  • Centre Jean Perrin Clermont-Ferrand, France
View all 16 locations
View Trial Details
Active, Not Recruiting

Phase I Trial of Defactinib and VS-6766.

NCT03875820

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +27 more
Locations
  • The Christie NHS Foundation Trust Manchester, Greater Manchester, United Kingdom
  • The Royal Marsden NHS Foundation Trust Sutton, Surrey, United Kingdom
  • The Royal Marsden NHS Foundation Trust - Gynecology Unit London, United Kingdom
  • The Newcastle Upon Tyne Hospitals NHS Foundation Trust - Freeman Hospital Newcastle, United Kingdom
View Trial Details
Active, Not Recruiting

ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss

NCT04065269

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +26 more
Locations
  • The Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
  • University of Montreal Hospital Centre Montreal, Quebec, Canada
  • Royal United Hospital Bath, United Kingdom
View Trial Details
Active, Not Recruiting

Cell-free DNA in Hereditary And High-Risk Malignancies 1

NCT04261972

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +33 more
Locations
  • BC Cancer Agency Vancouver, British Columbia, Canada
  • Eastern Health St. John's, Newfoundland and Labrador, Canada
  • IWK Health Centre Halifax, Nova Scotia, Canada
  • Sinai Health System Toronto, Ontario, Canada
View Trial Details
Active, Not Recruiting

Women at Risk of Breast Cancer and OLFM4

NCT02653105

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +20 more
Locations
  • Institut de Cancerologie de l'Ouest Angers, France
  • CHU Morvan Brest, France
  • Instit de Cancérologie de l'Ouest Nantes, France
  • CHBA Hopital Chubert Vannes, France
View Trial Details
Active, Not Recruiting

A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

NCT03522246

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +30 more
Locations
  • Arizona Oncology Associates, PC - HAL Phoenix, Arizona, United States
  • Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • John Muir Clinical Research Center Concord, California, United States
View all 238 locations
View Trial Details
Active, Not Recruiting

TH1902 in Patients With Advanced Solid Tumors

NCT04706962

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +57 more
Locations
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • START Midwest Grand Rapids, Michigan, United States
  • Pennsylvania Cancer Specialists Research Institute Gettysburg, Pennsylvania, United States
  • Mary Crowley Cancer Research Dallas, Texas, United States
View Trial Details

Related conditions